Skip to main content

Table 2 Clinical data

From: Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population

Type of AA

   (1) Multi-locular including ophiatic type (>40% of scalp hair loss)

11/27 (40.7%)

   (2) Subtotal, total

5/27 (18.6%)

   (3) Universalis, partim universalis

11/27 (40.7%)

Positive family history of:

   AA

10/27 (37%)

   Thyroid disease

7/27 (6%)

   DM

9/27 (33.3%)

Positive personal history of:

   Thyroid disease

3/27 (11.1%)

   DM

None

Presence of nail changes

16/27 (59.3%)

Presence of naevus simplex on the posterior neck

11/27 (40.7%)

Circulating ANA

None